Bruno | Health Researcher at HealAtlas

Fatty Liver Disease (MASLD): Diet, Lifestyle, and New Drugs

MASLD (formerly NAFLD) affects 1 in 4 adults. Here is what research shows about diet reversal, weight loss, and the FDA-approved drug Rezdiffra.

New research suggests cutting added sugar rapidly reshapes your gut microbiome — boosting diversity and easing inflammation-linked bacteria.

Research shows menopause hormone therapy can sharply reduce bone loss and fracture risk. Here’s what the latest evidence reveals about HRT.

ADHD in women is often missed for decades. New research explores delayed diagnosis, hormone links, and symptoms hiding as anxiety or burnout.

Should you take a daily aspirin? Updated USPSTF guidelines and three major trials reshaped who benefits—and who faces more harm than good.

Sleep apnea raises heart, brain, and metabolic risk. New research on tirzepatide, oral devices, and nerve stimulation expands options beyond CPAP.

Full-fat dairy was once vilified for saturated fat. New research on milk, cheese, and yogurt is rewriting that story. Here’s what the science says.

New research links higher ultra-processed food intake to weaker attention and rising dementia risk, even when overall diet quality is decent.

Survodutide cut weight 16.6% and liver fat 63% in Phase 3 trials while sparing lean mass. Here’s what the new dual GLP-1/glucagon drug does.

New research links higher vitamin C levels to preserved brain gray matter and stronger neural connectivity in older adults.